Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Farhat Nasim

Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Farhat Nasim

Articles By : Farhat Nasim

NPPA Panel Defers Biological E's Pneumonia Vaccine Price Exemption, Seeks Clarification

Farhat Nasim31 July 2025 11:00 PM IST

New Delhi: The National Pharmaceutical Pricing Authority (NPPA)'s Multidisciplinary Committee of Experts has asked Biological E Limited to submit...

Aurobindo Pharma Acquires Lannett for Rs 2,185 Cr to Boost U.S. Presence, ADHD Line

Farhat Nasim31 July 2025 2:48 PM IST

Hyderabad: In a major strategic move, Aurobindo Pharma Limited has announced that its wholly owned subsidiary, Aurobindo Pharma USA Inc, has entered...

CDSCO Panel Approves New Indications for Novo Nordisks Semaglutide, Mandates PMS Study

Novo Nordisk Appoints Mike Doustdar as New CEO Amid Executive Reshuffle

Farhat Nasim31 July 2025 2:30 PM IST

Delhi: Global healthcare major Novo Nordisk has announced the appointment of Maziar Mike Doustdar as its new President and Chief Executive Officer,...

Pharmacy Colleges in Trouble: Maharashtra Cracks Down on Institutions Failing PCI Standards

Farhat Nasim30 July 2025 6:06 PM IST

Mumbai: The Maharashtra government has issued a strong ultimatum to all B.Pharm and D.Pharm colleges in the state: comply with Pharmacy Council of...

Torrent Pharma Gears Up to Launch Oral, Injectable Semaglutide in 2026 Post Patent Expiry: Report

Farhat Nasim29 July 2025 10:09 PM IST

New Delhi: Torrent Pharmaceuticals is preparing to introduce both oral and injectable versions of Semaglutide, a blockbuster diabetes and weight loss...

Delhi HC directs State to expedite recruitment process of nursing officers, paramedical staff, specialist doctors

Roche Slammed for Seeking Zydus' Confidential Process for Cancer Drug Sigrima Without Meeting Patent Threshold

Farhat Nasim28 July 2025 6:29 PM IST

New Delhi: In a major relief to Zydus Lifesciences, the Delhi High Court dismissed F. Hoffmann-La Roche's plea seeking disclosure of Zydus'...

Telangana HRC Asks State to Pay Rs 1.25 L to 16 Victims Who Were Administered Expired Hepatitis B Vaccines

Pharma Firm Ignored Safety Gaps Before Deadly Blast, Paid Rs 32 Cr To Victims, Parliament Informed

Farhat Nasim27 July 2025 1:00 PM IST

New Delhi: In the aftermath of the fatal explosion at Escientia Advanced Sciences Pvt. Ltd. in Anakapalli, Andhra Pradesh, the Parliament was recently...

Sun Pharma net profit drops 20% to Rs 2,279 crore in Q1

Sun Pharma Agrees To Rs 1,654 Cr Settlement In U.S. Pricing Row

Farhat Nasim25 July 2025 5:29 PM IST

New Delhi: Sun Pharmaceutical Industries Ltd. has announced that its U.S. subsidiaries, Sun Pharmaceutical Industries Inc. and Taro Pharmaceuticals...

No Special Price for Novel Pack: NPPA Panel Turns Down Sun Pharma's Amoxicillin-Clavulanic Formulation

Farhat Nasim25 July 2025 5:24 PM IST

New Delhi: In a regulatory pushback against what it deemed an ineligible pricing request, the Multi-Disciplinary Committee (MDC) of the National...

NPPA Panel Rejects Dr Reddy's Omez ODT Plea For Seperate Price, Finds No Therapeutic Edge

Farhat Nasim24 July 2025 6:54 PM IST

New Delhi: In a decisive move against what it viewed as an unjustified price escalation, the Multi-Disciplinary Committee (MDC) under India's drug...

USFDA approves Zydus Lifesciences chronic idiopathic constipation drug Prucalopride

Delhi HC Bars Zydus From Launching Cancer Drug Nivolumab Biosimilar Till 2026

Farhat Nasim23 July 2025 4:45 PM IST

New Delhi: In a major setback to Zydus Lifesciences, the Delhi High Court has restrained the company from launching its proposed biosimilar of the...

1-Year Ban for Fake Docs, Mandatory Disposal of Near-Expiry Stock: CDSCO Revises Pharma Export Rules

Farhat Nasim21 July 2025 11:51 PM IST

New Delhi: The Central Drugs Standard Control Organisation (CDSCO) has issued a revised guidance document detailing the procedure for the issuance of...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok